Daily Glycaemic Variability in Frail or Disabled Older Patients With Diabetes Over 75 Treated With Basal Insulin
Status:
Completed
Trial end date:
2019-01-28
Target enrollment:
Participant gender:
Summary
Basal insulin is widely used in older patients with diabetes. Human insulin Neutral Protamine
Hagedorn (NPH) has been proposed as basal insulin in older (75 years or older) frail and
dependent patients due to its shorter action. However, no study has analysed the glycaemic
profile in elderly subjects according to the basal insulin used, particularly in frail or
disabled patients.
The aim of this study is to measure intra-day glycaemic variability according basal insulin
(human NPH or long acting analogues) in older (75 and older) frail or disabled patients with
diabetes using continuous glucose monitoring system.